(Q43288793)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19695513%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

review article

1 reference

title

Gastrointestinal hormones in food intake control (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19695513%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author

Lucas González-Matías

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19695513%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Mayte Alvarez Crespo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19695513%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Manuel Gil Lozano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19695513%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Soledad Fontans Paz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19695513%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Marina Romaní Pérez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19695513%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Eva Vigo Gago

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19695513%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Federico Mallo Ferrer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19695513%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

1 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19695513%20AND%20SRC:MED&resulttype=core&format=json

Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19695513%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19695513%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19695513%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

317-330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19695513%20AND%20SRC:MED&resulttype=core&format=json

Neuronal control of energy homeostasis

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Positional cloning of the mouse obese gene and its human homologue

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Prenatal imprinting of postnatal specific appetites and feeding behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Gastrointestinal regulation of food intake

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological properties

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Cholecystokinin elicits Satiety in Rats with Open Gastric Fistulas

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Effects of cholecystokinin-octapeptide (CCK-8) on food intake and gastric emptying in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Cholecystokinin-decreased food intake in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Abdominal Vagotomy Blocks the Satiety Effect of Cholecystokinin in the Rat

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Hyperphagia and obesity in OLETF rats lacking CCK-1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Satiety effects of a physiological dose of cholecystokinin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Long-term effects of CCK-agonist and -antagonist on food intake and body weight in Zucker lean and obese rats

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Stimulation of cholecystokinin-A receptors with GI181771X does not cause weight loss in overweight or obese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Rapid development of tolerance to the behavioural actions of cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Daily CCK injection enhances reduction of body weight by chronic intracerebroventricular leptin infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Cholecystokinin and leptin act synergistically to reduce body weight

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Central insulin enhances sensitivity to cholecystokinin.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

CCK inhibits the orexigenic effect of peripheral ghrelin

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

PYY inhibits CCK-stimulated pancreatic secretion through the area postrema in unanesthetized rats

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Effect of CCK-1 receptor blockade on ghrelin and PYY secretion in men

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Disturbed release of gastrointestinal peptides in anorexia nervosa and in obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Plasma cholecystokinin levels in Prader-Willi syndrome and obese subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Distribution of pancreatic polypeptide and peptide YY

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Structure and receptor binding of PYY analogs.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Effect of macronutrient composition on postprandial peptide YY levels

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

The role of PYY in feeding regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Preliminary report: role of peptide YY in defence against diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Gut hormone PYY(3-36) physiologically inhibits food intake

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Peptide YY(3-36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Inhibition of food intake in obese subjects by peptide YY3-36

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Lower mean weight after 14 days intravenous administration peptide YY3-36 (PYY3-36) in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Feeding after fourth ventricular administration of neuropeptide Y receptor agonists in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Attenuated peptide YY release in obese subjects is associated with reduced satiety.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

A role for pancreatic polypeptide in feeding and body weight regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Pancreatic polypeptide reduces appetite and food intake in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Characterization of the effects of pancreatic polypeptide in the regulation of energy balance

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Distribution of pancreatic polypeptide receptors in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Vagal, cholinergic regulation of pancreatic polypeptide secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Orexin neurons express a functional pancreatic polypeptide Y4 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Role of the Y5 neuropeptide Y receptor in feeding and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Increased cholecystokinin and pancreatic polypeptide responses to a fat-rich meal in patients with restrictive but not bulimic anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Low plasma levels of pancreatic polypeptide in obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Blunted pancreatic polypeptide responses in children with obesity of Prader-Willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Further purification of a polypeptide demonstrating enterogastrone activity

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Glucagon-like peptide 1 and gastric inhibitory polypeptide: potential applications in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Biology of incretins: GLP-1 and GIP

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Glycemic, hormone, and appetite responses to monosaccharide ingestion in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Gastric Inhibitory Polypeptide Enhanced Lipoprotein Lipase Activity in Cultured Preadipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Deficiency of glucose-dependent insulinotropic polypeptide receptor prevents ovariectomy-induced obesity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

(Pro(3))GIP[mPEG]: novel, long-acting, mPEGylated antagonist of gastric inhibitory polypeptide for obesity-diabetes (diabesity) therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

The Physiology of Glucagon-like Peptide 1

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

A role for glucagon-like peptide-1 in the central regulation of feeding

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Gut hormones in the control of appetite

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

The role of central glucagon-like peptide-1 in mediating the effects of visceral illness: differential effects in rats and mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Glucagon-like peptide 1 and its derivatives in the treatment of diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Cholecystokinin, glucose dependent insulinotropic peptide and glucagon-like peptide 1 secretion in children with anorexia nervosa and simple obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Exenatide: an incretin mimetic for the treatment of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Is parental control over children's eating associated with childhood obesity? Results from a population-based sample of third graders

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Exendin-4 potently decreases ghrelin levels in fasting rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Bioactive enteroglucagon (oxyntomodulin): Present knowledge on its chemical structure and its biological activities

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Oxyntomodulin: a cAMP-dependent stimulus of rat parietal cell function via the receptor for glucagon-like peptide-1 (7-36)NH2.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Stable expression of the rat GLP-I receptor in CHO cells: activation and binding characteristics utilizing GLP-I(7-36)-amide, oxyntomodulin, exendin-4, and exendin(9-39)

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Oxyntomodulin inhibits food intake in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Oxyntomodulin : a novel potential treatment for obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Oxyntomodulin from distal gut. Role in regulation of gastric and pancreatic functions.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Oxyntomodulin: a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Peripheral oxyntomodulin reduces food intake and body weight gain in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Differential hypothalamic neuronal activation following peripheral injection of GLP-1 and oxyntomodulin in mice detected by manganese-enhanced magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Oxyntomodulin suppresses appetite and reduces food intake in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satiety

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

No effect of physiological concentrations of glucagon-like peptide-2 on appetite and energy intake in normal weight subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Glucagon-like peptide 2 inhibits ghrelin secretion in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

A receptor in pituitary and hypothalamus that functions in growth hormone release

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Non-acylated ghrelin does not possess the pituitaric and pancreatic endocrine activity of acylated ghrelin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Post-prandial decrease of circulating human ghrelin levels

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

A transient surge of ghrelin secretion before feeding is modified by different feeding regimens in sheep

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

A role for ghrelin in the central regulation of feeding

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Ghrelin induces adiposity in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Circulating ghrelin levels are decreased in human obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Elevated plasma ghrelin levels in Prader–Willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Ghrelin stimulates GH but not food intake in arcuate nucleus ablated rats

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Site-specific effects of ghrelin on the neuronal activity in the hypothalamic arcuate nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Ghrelin-induced food intake is mediated via the orexin pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Vagotomy dissociates short- and long-term controls of circulating ghrelin

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Deletion of Ghrelin Impairs neither Growth nor Appetite

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Absence of ghrelin protects against early-onset obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Mice lacking ghrelin receptors resist the development of diet-induced obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Simultaneous deletion of ghrelin and its receptor increases motor activity and energy expenditure

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Antagonism of ghrelin receptor reduces food intake and body weight gain in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

A novel growth hormone secretagogue-1a receptor antagonist that blocks ghrelin-induced growth hormone secretion but induces increased body weight gain

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Obestatin reduces food intake and suppresses body weight gain in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Effects of obestatin on energy balance and growth hormone secretion in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Peripheral obestatin has no effect on feeding behavior and brain Fos expression in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

GPR39 signaling is stimulated by zinc ions but not by obestatin

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Obestatin does not activate orphan G protein-coupled receptor GPR39

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Biomedicine. Separation of conjoined hormones yields appetite rivals.

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)?

1 reference

https://api.crossref.org/works/10.1016%2FS1575-0922%2809%2971946-1

7 January 2021

10.1016/S1575-0922(09)71946-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19695513%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference